Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Gilbert

Showing results (261-270 of 453) with videos related to

Pageof 46
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 1, 2024
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic CellsHerui Wang, Rogelio Medina, Juan Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.
Scientific Reports|April 28, 2022
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patientsAshish H Shah, Vaidya Govindarajan, Tara T Doucet-O'Hare, et al.
Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Neurosurgery|July 17, 2018
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype GlioblastomaDrew Pratt, Gifty Dominah, Graham Lobel, et al.
Scientific Reports|July 1, 2022
Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse modelDorela D Shuboni-Mulligan, Demarrius Young, Julianie De La Cruz Minyety, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Cancer Medicine|March 7, 2025
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient PopulationBennett A McIver, Tara S Davis, Kimberly Reinhart, et al.
Journal of Neuro-Oncology|July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade gliomaTobias Walbert, Mark R Gilbert, Morris D Groves, et al.
Pageof 46

Showing results (261-270 of 453) with videos related to

Sort By:
Pageof 46
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 1, 2024
rWTC-MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic CellsHerui Wang, Rogelio Medina, Juan Ye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.
Scientific Reports|April 28, 2022
Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patientsAshish H Shah, Vaidya Govindarajan, Tara T Doucet-O'Hare, et al.
Neuro-Oncology|May 6, 2024
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020Mackenzie Price, Corey Neff, Nitin Nagarajan, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Neurosurgery|July 17, 2018
Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype GlioblastomaDrew Pratt, Gifty Dominah, Graham Lobel, et al.
Scientific Reports|July 1, 2022
Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse modelDorela D Shuboni-Mulligan, Demarrius Young, Julianie De La Cruz Minyety, et al.
International Journal of Oncology|February 13, 2015
Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastomaBenjamin M Ellingson, Eunhee Kim, Davis C Woodworth, et al.
Cancer Medicine|March 7, 2025
Evaluating Clinical and Sociodemographic Risk for Symptom Burden Associated Interference With Daily Functioning in the Primary Brain Tumor Patient PopulationBennett A McIver, Tara S Davis, Kimberly Reinhart, et al.
Journal of Neuro-Oncology|July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade gliomaTobias Walbert, Mark R Gilbert, Morris D Groves, et al.
Pageof 46